PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-28

Date Title Company
28-Apr-2020 Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus (COVID-19) Infections Pneumagen Ltd
28-Apr-2020 Marinomed receives FFG funding to research SARS-CoV-2 therapy based on Carragelose® Marinomed Biotech AG
28-Apr-2020 Bulletin from Moberg Pharma’s Extraordinary General Meeting on April 28th, 2020 Moberg Pharma
28-Apr-2020 Prokarium Signs an Exclusive Option Agreement with the Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois - CHUV) for the treatment of non-muscle invasive bladder cancer (NMIBC) Prokarium
28-Apr-2020 Sareum to Present at BioTrinity 2020 Sareum Holdings plc
28-Apr-2020 MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems of any manufacturer MR Solutions
28-Apr-2020 ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires B3C newswire
28-Apr-2020 PHARMIWEB AND TOPRA LAUNCH NEW JOB SHOP pharmiweb
28-Apr-2020 Fighting The COVID-19 Fire With Molecular Diagnostics, New IDTechEx Report on Innovations IDTechEx
28-Apr-2020 VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19 VistaGen Therapeutics
28-Apr-2020 Secarna Pharmaceuticals enters into cooperation with Guangzhou's Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections Secarna Pharmaceuticals GmbH & Co. KG
28-Apr-2020 New dates announced for Smart Water Systems 2020 SMi Group
28-Apr-2020 Visbion Image Cubes deployed at NHS Nightingale Hospitals across the UK Vidbion
28-Apr-2020 Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020 Theravance Biopharma, Inc.
28-Apr-2020 First Healthcare-Associated Infection Reduction Tied to Use of 90-Day Antimicrobial Coating, Study Indicates Allied BioScience
28-Apr-2020 Sweetwater Private Equity recognizes Adaptive Biotechnologies Corp. and its CEO Chad Robins for leadership during COVID-19 crisis Sweetwater Investment Management
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS Janssen
28-Apr-2020 Karus Therapeutics Announces New Data from Phase I Cancer Trial at AACR Karus Therapeutics Ltd
28-Apr-2020 Marinomed receives FFG funding to research SARS-CoV-2 therapy based on Carragelose® Marinomed
28-Apr-2020 MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System MagForce AG